Make greater efforts in base construction. Priorities will be attached to destitute areas such as Wuling Mountain Area, Wumeng Mountain Area and stony desertification areas in Yunnan, Guangxi and Guizhou. Projects will be set up through open competition. 37 counties (city, district, special administrative region) have been chosen to develop Chinese herbal medicine. The focus is to offer marketable medicines in China and raw materials for pharmaceutical companies in Guizhou. 23 varieties and commonly-used medicines have been selected as main herbs. On the basis of market demand and adaptability for the production of herbs, 27 kinds of herbs with sound industrial foundations are encouraged. They can be used as food and medicine at the same time. According to requirement of GAP, standardized planting bases of Chinese herbal medicine will be built and planting area of Chinese herbal medicine in each key county will be above 30,000 mu. Over one million mu planting area and industrial base of Chinese herbal medicine will be developed in Wuling Mountain Area, Wumeng Mountain Area and stony desertification areas in Yunnan, Guangxi and Guizhou. The following herbs will be grown such as gastrodia elata, eucommia ulmoides, radix pseudostellariae, pinellia ternate, dendrobe, blumea balsamifera, polygonum capitatum, herba epimedii, polygonum multiflorum, teasel root, uncaria etc. The scale of planting, output, market share and overall output value of these plants is aiming to take the lead in China. To take more market share and enhance competitive, the scales must be expanded. Five varieties are able to take up 60% of the market share in China. These efforts will make Chinese herbal medicine as an influential regional brand. By 2015 , the planting area of major varieties in key counties is to achieve about 2.5 million mu, which will fuel the growth of Chinese herbal medicine in Guizhou. Therefore, the planting area of herbs can reach five million mu. By that time, Guizhou will take the lead in terms of the planted area of herbs in China.

Pharmaceutical companies are encouraged to develop leading products of Chinese patented medicine, traditional Chinese medicine decoction pieces and traditional Chinese medicine extracts. In the meantime, they are recommended to be pioneers of chemical drugs and bio-medicine as well as leaders of production technology. Meanwhile, their business scopes shall be further expanded to food, healthcare products, daily use chemicals, disinfection and sterilization products, fertilizers and feed additives. The objective is to broaden business scope and extend industrial chain. More efforts will be made to develop enterprises of agriculture industrialization dedicated to grow traditional Chinese herbs and leading service-oriented companies for the distribution of traditional Chinese medicine. The target is to integrate pharmaceutical companies with herb-planting enterprises and distribution companies of medicine and herbs.

Better market system. Three to five regional trading markets for Chinese herbal medicine will be built in areas with concentrated enterprises of Chinese herbal medicine , such as in Zunyi, Bijie and Qiandongnan Autonomous Prefecture, located in Wuling Mountain Area, Wumeng Mountain Area and stony desertification areas in Yunnan, Guangxi and Guizhou. Seasonal trading markets will be set up in areas with over 1,000 mu areas of herb-planting. In the end, a market network covering the whole province can take shape.

Greater efforts will be exerted to register and apply trademarks, especially for herbal medicines of Miao Nationality. In addition, certification of standardization and place of origin shall be pressed ahead. More attention will also be given to apply famous and well-known trademarks so that Guizhou can become the Capital of Miao Nationality Herbal Medicine in China.